Biphenyl

Biphenyl

SCHEMBL184469

N=C=O.c1ccc(-c2ccccc2)cc1

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
CYP1A2 P05177 2/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
MAPK1 P28482 1/20 0.43
CYP3A4 P08684 1/20 0.43
TAAR1 Q96RJ0 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NOTUM Q6P988 1/20 0.43
MMP3 P08254 1/20 0.43
BCL2L1 Q07817 1/20 0.43
HSD17B3 P37058 1/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Biphenyl SCHEMBL8411194 1.00 ALDH1A1 (0.60) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL2136893 1.00 ALDH1A1 (0.60) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL48536 1.00 ALDH1A1 (0.60) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL27561764 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL28316594 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL27632954 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
SCHEMBL29442097 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
Tannin Pyrogallol SCHEMBL11218249 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL3908573 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT
Biphenyl SCHEMBL27760991 0.97 ALDH1A1 (0.56) ALDH1A1CYP1A2MAPTLMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 516 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115787192-B Preparation method of regenerated cowhide fiber synthetic leather 峰安皮业股份有限公司 2024-08-16 CN claimed
CN-114456112-B Synthesis method of benzanthracene derivative 安徽大学 2024-04-12 CN claimed
CN-113354778-B Solid polycarboxylate superplasticizer and preparation method thereof 中建西部建设建材科学研究院有限公司 2023-10-03 CN claimed
CN-116769094-A Binuclear vanadium catalyst containing binghAC ligand, and preparation method and application thereof 合肥工业大学 2023-09-19 CN claimed
CN-115093365-A Synthesis method of lefenacin 沈阳药科大学 2022-09-23 CN claimed
CN-113354778-A Solid polycarboxylic acid water reducing agent and preparation method thereof 中建西部建设建材科学研究院有限公司 2021-09-07 CN claimed
CN-104246914-B Insulated electric conductor and its manufacture method 住友电气工业株式会社 2017-07-07 CN claimed
CN-101747526-B Polymer microporous material and preparation method based on organic polymer network structure NAT CT NANOSCIENCE NCNST CHINA 2013-06-19 CN claimed
CN-102985507-A Foam sealing gasket SAINT GOBAIN PERFORMANCE PLAST 2013-03-20 CN claimed
US-8269025-B2 Purification of p-dioxanone TYCO HEALTHCARE GROUP LP (US) 2012-09-18 US claimed
US-20100004471-A1 PURIFICATION OF P-DIOXANONE COVIDIEN LP 2010-01-07 US claimed
EP-2141157-A1 Purification of p-dioxanone using isocyanate derivatives Tyco Healthcare Group LP (US) 2010-01-06 EP claimed
WO-2009043130-A1 IMPROVED SYSTEM AND MANUFACTURING PROCESS OF BIO- REPAIR OF SUBSTANCES IN THE LIQUID STATE WHICH CONTAIN CARBON MOLECULES IN ITS STRUCTURE FALNES ELINGSEN, HANS (BR) 2009-04-09 WO claimed
EP-1761554-A2 PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME Biosource Pharm, Inc. (US) 2007-03-14 EP claimed
WO-2006083317-A2 PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME BIOSOURCE PHARM, INC. (US) 2006-08-10 WO claimed
US-4607439-A AIR PERMEABLE MULTILAYER SHEET OF WATER AND OIL REPELLENT FABRIC AND RUBBER LAYER ACHILLES CORPORATION (JP) 1986-08-26 US claimed
EP-0019349-B1 STABILIZING COMPOSITION FOR POLYARYLENE ESTERS, STABILIZED POLYARYLENE ESTER, MOULDED ARTICLE PRODUCED THEREFROM AND PROCESS FOR STABILIZING A POLYARYLENE ESTER MONSANTO COMPANY (US) 1983-08-03 EP claimed
EP-0019349-A1 Stabilizing composition for polyarylene esters, stabilized polyarylene ester, moulded article produced therefrom and process for stabilizing a polyarylene ester MONSANTO COMPANY (US) 1980-11-26 EP claimed
US-4222932-A MOLDING MATERIALS STABILIZED BY ADDING AN AROMATIC ISOCYANATE AND AN ALIPHATIC PHOSPHITE MONSANTO COMPANY (US) 1980-09-16 US claimed
CN-122079865-A Preparation method and application of key intermediate of Revelinaxin 2026-05-26 CN disclosed
CN-121045796-A Modified sulfonated polyether-ether-ketone proton exchange membrane and preparation method and application thereof 江苏科润膜材料有限公司 2025-12-02 CN disclosed
US-12264073-B2 Composite material ADEKA CORPORATION (JP) 2025-04-01 US disclosed
CN-119591537-A Rafenacin Process for the preparation of intermediates 山东新时代药业有限公司 2025-03-11 CN disclosed
US-12145913-B2 Inhibition of Olig2 activity Curtana Pharmaceuticals, Inc. (US) 2024-11-19 US disclosed
CN-118852224-A Beta-ketoamine non-noble metal complex and preparation method and application thereof 北京理工大学 2024-10-29 CN disclosed
CN-115787192-B Preparation method of regenerated cowhide fiber synthetic leather 峰安皮业股份有限公司 2024-08-16 CN disclosed
CN-114380874-B Macrolide antibiotics, preparation method and application thereof 中国医学科学院医药生物技术研究所 2024-06-21 CN disclosed
CN-117263850-A Synthesis method of raffinacine 华中药业股份有限公司 2023-12-22 CN disclosed
CN-117263850-A Synthesis method of raffinacine 华中药业股份有限公司 2023-12-22 CN disclosed
CN-113354778-B Solid polycarboxylate superplasticizer and preparation method thereof 中建西部建设建材科学研究院有限公司 2023-10-03 CN disclosed
CN-116769094-A Binuclear vanadium catalyst containing binghAC ligand, and preparation method and application thereof 合肥工业大学 2023-09-19 CN disclosed
CN-116615480-A Thermosetting epoxy resin composition, molded article thereof, fiber-reinforced composite material, molded material for fiber-reinforced composite material, and method for producing fiber-reinforced composite material 东丽株式会社 2023-08-18 CN disclosed
CN-116601185-A Olefin composition comprising hydrocarbon resin 马特里亚公司 2023-08-15 CN disclosed
WO-2023101379-A1 ISOCYANATE COMPOSITION AND OPTICAL COMPOSITION 한화솔루션 주식회사 2023-06-08 WO disclosed
WO-2023089999-A1 RADICAL CURABLE RESIN COMPOSITION, FIBER-REINFORCED MOLDING MATERIAL, AND MOLDED ARTICLE USING SAME DIC株式会社 2023-05-25 WO disclosed
CN-109666158-B Hybrid dynamic polymer and application thereof 厦门逍扬运动科技有限公司 2023-04-07 CN disclosed
CN-115850157-A Preparation method of 1-benzylpiperidine-4-yl [1,1' -biphenyl ] -2-yl carbamate 济南大学 2023-03-28 CN disclosed
CN-115787192-A Preparation method of regenerated cow leather fiber synthetic leather 峰安皮业股份有限公司 2023-03-14 CN disclosed
CN-115403509-A Preparation method of lefenacin intermediate 山东新时代药业有限公司 2022-11-29 CN disclosed
CN-113754694-B Method for synthesizing Reidesvir by asymmetric catalysis of non-protecting group nucleoside 上海交通大学 2022-10-25 CN disclosed
CN-115215807-A Inhibition of OLIG2 activity 科泰纳制药公司 2022-10-21 CN disclosed
CN-115093365-A Synthesis method of lefenacin 沈阳药科大学 2022-09-23 CN disclosed
CN-115093365-A Synthesis method of lefenacin 沈阳药科大学 2022-09-23 CN disclosed
CN-113754693-B Asymmetric catalytic synthesis method and catalyst of phosphorus chiral nucleoside derivative 上海交通大学 2022-09-09 CN disclosed
CN-111868130-B Composition, bonding method and assembly 3M创新有限公司 2022-06-24 CN disclosed
CN-111788246-B Composition, bonding method and bonded assembly 3M创新有限公司 2022-06-10 CN disclosed
CN-113754692-B Asymmetric catalytic synthesis method of Ruideciclovir intermediate (S, S) -phosphoramidate 上海交通大学 2022-06-10 CN disclosed
CN-114040934-A Polymerizable composition for producing polyisocyanurate-based plastics having extended pot life 科思创知识产权两合公司 2022-02-11 CN disclosed
US-11242323-B2 Inhibition of OLIG2 activity Curtana Pharmaceuticals, Inc. (US) 2022-02-08 US disclosed
CN-113754694-A Method for synthesizing Reidesvir by asymmetric catalysis of non-protecting group nucleoside 上海交通大学 2021-12-07 CN disclosed
CN-113754692-A Asymmetric catalytic synthesis method of Ruideciclovir intermediate (S, S) -phosphoramidate 上海交通大学 2021-12-07 CN disclosed
CN-113754693-A Asymmetric catalytic synthesis method and catalyst of phosphorus chiral nucleoside derivative 上海交通大学 2021-12-07 CN disclosed
WO-2021215606-A1 DIISOCYANATE COMPOSITION AND OPTICAL LENS PRODUCED USING SAME 에스케이씨 주식회사 (KR) 2021-10-28 WO disclosed
CN-113423549-A Coating composition 马特里亚公司 2021-09-21 CN disclosed
CN-108884208-B Thermosetting resin composition, sheet molding compound, method for producing same, and fiber-reinforced composite material 三菱化学株式会社 2021-09-21 CN disclosed
CN-113354778-A Solid polycarboxylic acid water reducing agent and preparation method thereof 中建西部建设建材科学研究院有限公司 2021-09-07 CN disclosed
US-20210253535-A1 INHIBITION OF OLIG2 ACTIVITY Curtana Pharmaceuticals, Inc. 2021-08-19 US disclosed
US-20210221689-A1 COMPOSITE MATERIAL ADEKA CORPORATION (JP) 2021-07-22 US disclosed
CN-107849816-B Method for treating paperboard and paper media and related treated paperboard and paper media 巴斯夫欧洲公司 2021-07-09 CN disclosed
CN-113024462-A Method for efficiently preparing phenanthridinone and derivatives thereof without metal participation 清华大学 2021-06-25 CN disclosed
EP-3831776-A1 COMPOSITE MATERIAL ADEKA CORPORATION (JP) 2021-06-09 EP disclosed
CN-112714775-A Heat-curable one-piece composition 3M创新有限公司 2021-04-27 CN disclosed
CN-112424120-A Composite material 株式会社艾迪科 2021-02-26 CN disclosed
US-10920009-B2 Thermosetting resin composition, sheet-molding compound and production method therefor, and fiber-reinforced composite material MITSUBISHI CHEMICAL CORPORATION (JP) 2021-02-16 US disclosed
CN-112020525-A Adducts of amine catalysts for making isocyanurate polymers 科思创知识产权两合公司 2020-12-01 CN disclosed
CN-111868130-A Composition, bonding method and assembly 3M创新有限公司 2020-10-30 CN disclosed
CN-107223121-B Wet stable holographic media 科思创德国股份有限公司 2020-10-27 CN disclosed
CN-111788246-A Composition, bonding method and bonded assembly 3M创新有限公司 2020-10-16 CN disclosed
EP-3720914-A1 AQUEOUS COATING COMPOSITIONS FOR FORMING ANTI-GRAIN-PUFFING COATINGS ON WOOD SUBSTRATE, AQUEOUS PAINTS AND ARTICLES Guangdong Huarun Paints Co., Ltd. (CN) 2020-10-14 EP disclosed
CN-106029802-B Addition-fragmentation oligomers with high refractive index groups 3M创新有限公司 2020-08-18 CN disclosed
EP-3233791-B1 MOISTURE STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2020-08-12 EP disclosed
CN-107556433-B Dynamic polymer elastomer with hybrid cross-linked network and application thereof 翁秋梅 2020-07-31 CN disclosed
EP-2976323-B1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2020-07-15 EP disclosed
EP-3441409-B1 THERMOSETTING RESIN COMPOSITION, SHEET-MOLDING COMPOUND AND PRODUCTION METHOD THEREFOR, AND FIBER-REINFORCED COMPOSITE MATERIAL MITSUBISHI CHEM CORP (JP) 2020-06-03 EP disclosed
EP-3625291-A1 VULCANIZABLE COMPOSITION AND MOLDABLE THERMOPLASTIC ELASTOMER PRODUCT THEREFROM Kuraray Co., Ltd. (JP) 2020-03-25 EP disclosed
WO-2020027023-A1 COMPOSITE MATERIAL 株式会社ADEKA 2020-02-06 WO disclosed
CN-106232667-B Polyiso-ureas 巴斯夫欧洲公司 2020-01-07 CN disclosed
CN-110591153-A Flame retardant, precursor thereof and flame-retardant material 德生智权有限公司 2019-12-20 CN disclosed
US-10407449-B1 Flame retardant, precursor thereof, and flame retardant material X-EXTREME PTE. LTD. (TW) 2019-09-10 US disclosed
CN-106133886-B Semiconductor element and composition for forming insulating layer 富士胶片株式会社 2019-07-30 CN disclosed
CN-106752926-B A kind of graphene/polysiloxanes composite coating material and preparation method thereof 复旦大学 2019-07-05 CN disclosed
EP-3504195-A1 INHIBITION OF OLIG2 ACTIVITY Curtana Pharmaceuticals, Inc. (US) 2019-07-03 EP disclosed
US-10329244-B2 Moisture-stable holographic media COVESTRO DEUTSCHLAND AG (DE) 2019-06-25 US disclosed
WO-2019113402-A1 AQUEOUS COATING COMPOSITIONS FOR FORMING ANTI-GRAIN-PUFFING COATINGS ON WOOD SUBSTRATE, AQUEOUS PAINTS AND ARTICLES THE SHERWIN-WILLIAMS COMPANY (US) 2019-06-13 WO disclosed
CN-109666165-A A kind of energy-absorbing method based on dynamic aggregation compositions 翁秋梅 2019-04-23 CN disclosed
CN-109666178-A A kind of hydridization dynamic aggregation compositions and its application 翁秋梅 2019-04-23 CN disclosed
CN-109666164-A A kind of energy-absorbing method based on dynamic aggregation compositions 翁秋梅 2019-04-23 CN disclosed
CN-109666130-A A kind of energy-absorbing method based on dynamic aggregation object 翁秋梅 2019-04-23 CN disclosed
CN-109666157-A A kind of hydridization dynamic aggregation object and its application 翁秋梅 2019-04-23 CN disclosed
CN-109666161-A A kind of energy-absorbing method based on dynamic aggregation object 翁秋梅 2019-04-23 CN disclosed
CN-109666153-A A kind of hydridization dynamic aggregation compositions and its application 翁秋梅 2019-04-23 CN disclosed
CN-109666158-A A kind of hydridization dynamic aggregation object and its application 翁秋梅 2019-04-23 CN disclosed
US-20190105237-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2019-04-11 US disclosed
CN-109423148-A A kind of energy-absorbing method based on dynamic aggregation object 翁秋梅 2019-03-05 CN disclosed
EP-3441409-A1 THERMOSETTING RESIN COMPOSITION, SHEET-MOLDING COMPOUND AND PRODUCTION METHOD THEREFOR, AND FIBER-REINFORCED COMPOSITE MATERIAL Mitsubishi Chemical Corporation (JP) 2019-02-13 EP disclosed
US-10195119-B2 High refractive index addition-fragmentation agents 3M INNOVATIVE PROPERTIES COMPANY (US) 2019-02-05 US disclosed
CN-103965134-B It is a kind of to contain N, S heterocyclic compound and its preparation method and purposes with eelworm-killing activity 华东理工大学 2019-02-05 CN disclosed
US-20190031817-A1 THERMOSETTING RESIN COMPOSITION, SHEET-MOLDING COMPOUND AND PRODUCTION METHOD THEREFOR, AND FIBER-REINFORCED COMPOSITE MATERIAL MITSUBISHI CHEMICAL CORPORATION (JP) 2019-01-31 US disclosed
CN-103965133-B It is a kind of to contain N, S heterocyclic compound and its preparation and use with DHODH inhibitory activity 华东理工大学 2018-11-30 CN disclosed
WO-2018213462-A1 VULCANIZABLE COMPOSITION AND MOLDABLE THERMOPLASTIC ELASTOMER PRODUCT THEREFROM KURARAY CO., LTD. (JP) 2018-11-22 WO disclosed
US-20180334521-A1 VULCANIZABLE COMPOSITION AND MOLDABLE THERMOPLASTIC ELASTOMER PRODUCT THEREFROM KURARAY CO., LTD. (JP) 2018-11-22 US disclosed
CN-107935944-A With the double aryl ureas quinoxaline derivants of antitumor activity and its synthetic method 广西师范大学 2018-04-20 CN disclosed
EP-3304196-A1 THERMALLY DEVELOPABLE IMAGING MATERIALS AND METHODS Carestream Health, Inc. (US) 2018-04-11 EP disclosed
WO-2018039621-A1 INHIBITION OF OLIG2 ACTIVITY Curtana Pharmaceuticals, Inc. (US) 2018-03-01 WO disclosed
EP-2925760-B1 C20'-SUBSTITITED UREA DERIVATIVES OF VINCA ALKALOIDS SCRIPPS RESEARCH INST (US) 2018-02-21 EP disclosed
CN-107690601-A The image forming material and method of heat-developable 卡尔斯特里姆保健公司 2018-02-13 CN disclosed
CN-107683298-A Memory Foam Based On Thermoplastic Polyurethane 巴斯夫欧洲公司 2018-02-09 CN disclosed
CN-107556433-A A kind of dynamic aggregation thing elastomer and its application with hybrid cross-linked network 翁秋梅 2018-01-09 CN disclosed
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2017-12-21 US disclosed
EP-3233791-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA Covestro Deutschland AG (DE) 2017-10-25 EP disclosed
US-9746770-B2 Thermally developable imaging materials and methods CARESTREAM HEALTH, INC. (US) 2017-08-29 US disclosed
US-9730864-B2 Addition-fragmentation oligomers having high refractive index groups 3M INNOVATIVE PROPERTIES COMPANY (US) 2017-08-15 US disclosed
CN-104246914-B Insulated electric conductor and its manufacture method 住友电气工业株式会社 2017-07-07 CN disclosed
CN-103748165-B The adhesion promotor and gel modifying agent of olefin metathesis composition 马特里亚公司 2017-06-09 CN disclosed
CN-106752926-A A kind of Graphene/polysiloxanes composite coating material and preparation method thereof 复旦大学 2017-05-31 CN disclosed
CN-106752923-A A kind of damage resistant high, abrasion-resistant coatings material and preparation method thereof 复旦大学 2017-05-31 CN disclosed
US-9634271-B2 Semiconductor device, method of manufacturing the same, and electronic apparatus SONY CORPORATION (JP) 2017-04-25 US disclosed
CN-106565674-A Octahydrocyclopentano[c]pyrrole derivatives, and preparation methods and medicinal application thereof 四川海思科制药有限公司 2017-04-19 CN disclosed
CN-103633244-B Semiconductor device, method of manufacturing the same, and electronic apparatus 索尼公司 2017-04-12 CN disclosed
US-9611271-B2 C20′ urea derivatives of vinca alkaloids SCRIPPS RESEARCH INSTITUTE (US) 2017-04-04 US disclosed
CN-106459332-A Aqueous polyurethane resin dispersion 宇部兴产株式会社 2017-02-22 CN disclosed
CN-106462051-A Thermally developable imaging materials 卡尔斯特里姆保健公司 2017-02-22 CN disclosed
CN-106414536-A Aqueous polyurethane resin dispersion 宇部兴产株式会社 2017-02-15 CN disclosed
CN-104884493-B Aqueous polyurethane resin dispersion and use of same 宇部兴产株式会社 2017-02-08 CN disclosed
EP-3123244-A1 THERMALLY DEVELOPABLE IMAGING MATERIALS Carestream Health, Inc. (US) 2017-02-01 EP disclosed
US-20170018726-A1 ELECTRONIC DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2017-01-19 US disclosed
EP-3107975-A1 ADDITION-FRAGMENTATION OLIGOMERS HAVING HIGH REFRACTIVE INDEX GROUPS 3M Innovative Properties Company (US) 2016-12-28 EP disclosed
US-20160357104-A1 THERMALLY DEVELOPABLE IMAGING MATERIALS AND METHODS CARESTREAM HEALTH WORLD HOLDINGS LLC 2016-12-08 US disclosed
CN-106211775-A Composition for optical material and application thereof 三菱瓦斯化学株式会社 2016-12-07 CN disclosed
US-20160346170-A1 ADDITION-FRAGMENTATION OLIGOMERS HAVING HIGH REFRACTIVE INDEX GROUPS 3M INNOVATIVE PROPERTIES COMPANY 2016-12-01 US disclosed
CN-106133886-A Semiconductor element and composition for forming insulating layer 富士胶片株式会社 2016-11-16 CN disclosed
US-9458251-B2 Cellulose resin and process for producing the same NEC CORPORATION (JP) 2016-10-04 US disclosed
US-20160279033-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES COMPANY 2016-09-29 US disclosed
WO-2016096641-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2016-06-23 WO disclosed
US-9335623-B2 Thermally developable imaging materials CARESTREAM HEALTH, INC. (US) 2016-05-10 US disclosed
CN-102779949-B Thin-film component assembly SONY CORP (JP) 2016-03-23 CN disclosed
US-9293719-B2 Semiconductor device, method of manufacturing the same, and electronic apparatus SONY CORPORATION (JP) 2016-03-22 US disclosed
CN-105307863-A Decorative moulding film, and decorative moulded article TORAY INDUSTRIES 2016-02-03 CN disclosed
EP-2976323-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS 3M Innovative Properties Company (US) 2016-01-27 EP disclosed
US-9181351-B2 Cellulose resin and process for producing the same NEC CORPORATION (JP) 2015-11-10 US disclosed
US-20150291610-A1 C20' Urea Derivatives of Vinca Alkaloids NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-10-15 US disclosed
EP-2925760-A1 C20'-UREA DERIVATIVES OF VINCA ALKALOIDS The Scripps Research Institute (US) 2015-10-07 EP disclosed
CN-104955901-A Heat-curable adhesive composition ADEKA CORP 2015-09-30 CN disclosed
US-20150268550-A1 THERMALLY DEVELOPABLE IMAGING MATERIALS CARESTREAM HEALTH ACQUISITION, LLC 2015-09-24 US disclosed
CN-104884493-A Aqueous polyurethane resin dispersion and use of same UBE INDUSTRIES 2015-09-02 CN disclosed
CN-103502316-B multifunctional sulfur-containing polymers, compositions and methods of use thereof PRC-DESOTO INTERNATIONAL, INC. (US) 2015-09-02 CN disclosed
WO-2015126657-A1 ADDITION-FRAGMENTATION OLIGOMERS HAVING HIGH REFRACTIVE INDEX GROUPS 3M INNOVATIVE PROPERTIES COMPANY (US) 2015-08-27 WO disclosed
US-9057946-B2 Difunctional (meth)acrylate writing monomers BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-06-16 US disclosed
CN-101679432-B Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC 2015-04-22 CN disclosed
US-8992731-B2 Modified cellulose fibers and cellulose composite thereof MITSUBISHI CHEMICAL CORPORATION (JP) 2015-03-31 US disclosed
US-20150060802-A1 ELECTRONIC DEVICE, MANUFACTURING METHOD THEREOF, AND IMAGE DISPLAY DEVICE SONY CORPORATION (JP) 2015-03-05 US disclosed
EP-2838118-A1 ELECTRONIC DEVICE, METHOD FOR MANUFACTURING SAME, AND IMAGE DISPLAY DEVICE Sony Corporation (JP) 2015-02-18 EP disclosed
CN-102803600-B Modified cellulose fiber and cellulose composite thereof MITSUBISHI CHEM CORP 2015-01-14 CN disclosed
CN-101875961-B Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related therto ARENA PHARM INC 2015-01-07 CN disclosed
US-8889826-B2 Peptide antibiotics and methods for making same BIOSOURCE PHARM, INC. (US) 2014-11-18 US disclosed
CN-104137267-A Electronic device, electronic device manufacturing method, and image display apparatus SONY CORP 2014-11-05 CN disclosed
US-20140291659-A1 DIOXAANTHANTHRENE COMPOUND, LAMINATED STRUCTURE AND FORMATION METHOD THEREOF, AND ELECTRONIC DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2014-10-02 US disclosed
WO-2014151363-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES COMPANY (US) 2014-09-25 WO disclosed
WO-2014141035-A2 FUSED HETEROCYCLYL DERIVATIVES AS NAMPT INHIBITORS AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2014-09-18 WO disclosed
EP-2767540-A1 DIOXAANTHANTHRENE-BASED COMPOUND, LAMINATED STRUCTURE AND MOLDING METHOD THEREOF, AND ELECTRONIC DEVICE AND PRODUCTION METHOD THEREOF Sony Corporation (JP) 2014-08-20 EP disclosed
EP-1923425-B1 Thermoplastic elastomer composition KURARAY CO (JP) 2014-08-06 EP disclosed
CN-103965134-A N, S-containing heterocyclic compound with nematicidal activity, preparation method and application thereof UNIV EAST CHINA SCIENCE & TECH 2014-08-06 CN disclosed
CN-103965133-A N, S heterocycle-containing compound having DHODH inhibition activity, preparation and use thereof UNIV EAST CHINA SCIENCE & TECH 2014-08-06 CN disclosed
US-8772307-B2 Substituted spiro compounds and their use for producing pain-relief medicaments GRUENENTHAL GMBH (DE) 2014-07-08 US disclosed
WO-2014088657-A1 C20'-UREA DERIVATIVES OF VINCA ALKALOIDS THE SCRIPPS RESEARCH INSTITUTE (US) 2014-06-12 WO disclosed
US-20140117280-A1 OXYGEN ABSORBER MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-05-01 US disclosed
EP-2711077-A1 OXYGEN ABSORBER Mitsubishi Gas Chemical Company, Inc. (JP) 2014-03-26 EP disclosed
CN-103633244-A Semiconductor device, method of manufacturing the same, and electronic apparatus SONY CORP 2014-03-12 CN disclosed
CN-101701006-B Phenethanolamine derivatives for treatment of respiratory diseases GLAXO GROUP LTD 2014-03-05 CN disclosed
US-20140054568-A1 SEMICONDUCTOR DEVICE, METHOD OF MANUFACTURING THE SAME, AND ELECTRONIC APPARATUS SONY CORPORATION (JP) 2014-02-27 US disclosed
US-20140024824-A1 CELLULOSE RESIN AND PROCESS FOR PRODUCING THE SAME NEC CORPORATION (JP) 2014-01-23 US disclosed
CN-103534295-A Terminal-modified difunctional sulfur-containing polymers, compositions thereof and methods of use PRC DESOTO INT INC 2014-01-22 CN disclosed
US-20140018530-A1 CELLULOSE RESIN AND PROCESS FOR PRODUCING THE SAME NEC CORPORATION (JP) 2014-01-16 US disclosed
CN-103502316-A Multifunctional sulfur-containing polymers, compositions and methods of use thereof PRC DESOTO INT INC 2014-01-08 CN disclosed
EP-2441885-B1 MODIFIED CELLULOSE FIBER AND CELLULOSE COMPOSITE THEREOF MITSUBISHI CHEM CORP (JP) 2013-11-27 EP disclosed
US-20130252140-A1 DIFUNCTIONAL (METH)ACRYLATE WRITING MONOMERS BAYER MATERIALSCIENCE AG (DE) 2013-09-26 US disclosed
CN-103288793-A Phenethanolamine derivatives for treatment of respiratory diseases GLAXO GROUP LTD 2013-09-11 CN disclosed
US-8501992-B2 Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-08-06 US disclosed
CN-101747526-B Polymer microporous material and preparation method based on organic polymer network structure NAT CT NANOSCIENCE NCNST CHINA 2013-06-19 CN disclosed
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 US disclosed
US-8440830-B2 Tetrahydro-fused pyridines as histone deacetylase inhibitors 4SC AG (DE) 2013-05-14 US disclosed
CN-102985507-A Foam sealing gasket SAINT GOBAIN PERFORMANCE PLAST 2013-03-20 CN disclosed
CN-101535380-B Metal coordinating and film-forming materials BASF CORP 2012-11-28 CN disclosed
CN-102803600-A Modified cellulose fiber and cellulose composite thereof MITSUBISHI CHEM CORP 2012-11-28 CN disclosed
EP-2197552-B1 NOVEL TETRAHYDROFUSEDPYRIDINES AS HISTONE DEACETYLASE INHIBITORS 4SC AG (DE) 2012-11-21 EP disclosed
US-20120288685-A1 THIN-FILM ELEMENT ASSEMBLY SONY CORPORATION (JP) 2012-11-15 US disclosed
CN-102779949-A Thin-film element assembly SONY CORP 2012-11-14 CN disclosed
CN-102753612-A Process for the preparation of thermoplastic compositions of plasticized starch and such compositions ROQUETTE FRERES 2012-10-24 CN disclosed
CN-101910240-B Latent curing agent, epoxy resin composition containing same, sealing agent, and organic EL display MITSUI CHEMICALS INC 2012-10-03 CN disclosed
US-8269025-B2 Purification of p-dioxanone TYCO HEALTHCARE GROUP LP (US) 2012-09-18 US disclosed
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF BAYER INTELLECTUAL PROPERTY GMBH (DE) 2012-08-30 US disclosed
CN-101679312-B 3, 4-dihydroquinazoline derivatives DONGWOO SYNTECH CO LTD 2012-08-08 CN disclosed
CN-101687975-B Low volatiles coatings, sealants and binders from renewable oils DOW GLOBAL TECHNOLOGIES INC 2012-06-27 CN disclosed
CN-101535421-B Method for producing coatings with metal coordinating and film-forming materials BASF CORP 2012-06-20 CN disclosed
CN-101472925-B As adenosine A2APurine derivatives of receptor agonists NOVARTIS AG 2012-06-13 CN disclosed
US-20120125547-A1 MODIFIED CELLULOSE FIBERS AND CELLULOSE COMPOSITE THEREOF MITSUBISHI CHEMICAL CORPORATION (JP) 2012-05-24 US disclosed
EP-2441885-A1 MODIFIED CELLULOSE FIBER AND CELLULOSE COMPLEX COMPRISING SAME Mitsubishi Chemical Corporation (JP) 2012-04-18 EP disclosed
CN-1826322-B Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor for the prevention and treatment of related disorders ARENA PHARM INC 2012-04-18 CN disclosed
CN-102395277-A Encapsulation of herbicides to reduce crop injury MONSANTO TECHNOLOGY LLC 2012-03-28 CN disclosed
CN-101734653-B Method for preparing graphite oxide-based aperture adjustable nano porous material NAT CT NANOSCIENCE NCNST CHINA 2012-01-25 CN disclosed
CN-1890359-B Adhesion inhibition of micro organisms by non-ionic surfactants HENKEL AG & CO KGAA 2012-01-11 CN disclosed
US-8093245-B2 Anticancer agents; potent Deoxycytidine kinase inhibitors; inhibit thymidine kinase; inhibit uridine kinase; N-[3-(4-amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-cyclopentyl]-3-bromo-benzenesulfonamide LEXICON PHARMACEUTICALS, INC. (US) 2012-01-10 US disclosed
EP-2297103-B1 HYDROXYPHENYLSULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2012-01-04 EP disclosed
US-20110294793-A1 HYDROXYPHENYL SULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2011-12-01 US disclosed
US-8034875-B2 Elastomer and vulcanizate compositions having desirable high temperature properties TEKNOR APEX COMPANY (US) 2011-10-11 US disclosed
CN-102209758-A Polyaminoacetonitriles, their methods of preparation and use HUNTSMAN PETROCHEMICAL LLC 2011-10-05 CN disclosed
EP-2332965-A1 Peptide antibiotics and methods for making same BioSource Pharm, Inc. (US) 2011-06-15 EP disclosed
CN-102070931-A Ultraviolet absorbent for paint SUZHOU MEIYAMEI CONSTRUCTION COATINGS CO LTD 2011-05-25 CN disclosed
US-7919508-B2 3-piperidinylisochroman-5-ols as dopamine agonists AVENTIS PHARMACEUTICALS INC. (US) 2011-04-05 US disclosed
EP-2297103-A1 HYDROXYPHENYLSULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS Bristol-Myers Squibb Company (US) 2011-03-23 EP disclosed
US-7910647-B2 Adhesion inhibition of microorganisms by non-ionic surfactants HENKEL AG & CO. KGAA (DE) 2011-03-22 US disclosed
US-20110040047-A1 Elastomer and vulcanizate compositions having desirable high temperature properties TEKNOR APEX COMPANY (US) 2011-02-17 US disclosed
US-20110028442-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR ALMIRALL, S.A. (ES) 2011-02-03 US disclosed
US-20110021494-A1 NOVEL TETRAHYDRO-FUSED PYRIDINES AS HISTONE DEACETYLASE INHIBITORS 4SC AG (DE) 2011-01-27 US disclosed
CN-101910240-A Latent curing agent, epoxy resin composition containing same, sealing agent, and organic EL display MITSUI CHEMICALS INC 2010-12-08 CN disclosed
US-7847024-B2 Elastomer and vulcanizate compositions having desirable high temperature properties TEKNOR APEX COMPANY (US) 2010-12-07 US disclosed
EP-2254860-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR Almirall, S.A. (ES) 2010-12-01 EP disclosed
CN-1989164-B Curable composition THREE BOND CO LTD 2010-11-24 CN disclosed
CN-101875961-A Be used to prevent and treat associated conditions and as the diaryl and the aryl heteroaryl urea derivatives of 5-HT2A serotonin receptor modulator ARENA PHARM INC 2010-11-03 CN disclosed
CN-101871931-A Be used to prevent and treat associated conditions and as the diaryl and the aryl heteroaryl urea derivatives of 5-HT2A serotonin receptor modulator ARENA PHARM INC 2010-10-27 CN disclosed
CN-1585633-B Phenylethanolamine derivatives for the treatment of respiratory diseases GLAXO GROUP LTD 2010-10-27 CN disclosed
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS MITSUI CHEMICALS, INC (JP) 2010-10-07 US disclosed
US-7772183-B2 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2010-08-10 US disclosed
EP-2199313-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONATING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS Mitsui Chemicals, Inc. (JP) 2010-06-23 EP disclosed
EP-2197552-A2 NOVEL TETRAHYDROFUSEDPYRIDINES AS HISTONE DEACETYLASE INHIBITORS 4SC AG (DE) 2010-06-23 EP disclosed
CN-101747526-A Polymer microporous material and preparation method based on organic polymer network structure NAT CT NANOSCIENCE NCNST CHINA 2010-06-23 CN disclosed
CN-101734653-A Method for preparing graphite oxide-based aperture adjustable nano porous material NAT CT NANOSCIENCE NCNST CHINA 2010-06-16 CN disclosed
US-20100137402-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2010-06-03 US disclosed
CN-101701006-A Phenethanolamine derivatives for treatment of respiratory diseases GLAXO GROUP LTD 2010-05-05 CN disclosed
CN-1556705-B 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives ACTELION PHARMACEUTICALS LTD 2010-04-28 CN disclosed
CN-101687975-A Low volatiles coatings, sealants and binders from renewable oils DOW GLOBAL TECHNOLOGIES INC 2010-03-31 CN disclosed
US-7687537-B2 N-[(4,5-diphenyl-2-thienyl)methyl]amine derivatives, their preparation and their therapeutic application SANOFI-AVENTIS (FR) 2010-03-30 US disclosed
CN-101679432-A Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors SIGNAL PHARM LLC 2010-03-24 CN disclosed
CN-101679312-A 3, 4-dihydroquinazoline derivatives DONGWOO SYNTECH CO LTD 2010-03-24 CN disclosed
EP-1749001-B1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMA INC (US) 2010-03-03 EP disclosed
US-20100004471-A1 PURIFICATION OF P-DIOXANONE COVIDIEN LP 2010-01-07 US disclosed
EP-2141157-A1 Purification of p-dioxanone using isocyanate derivatives Tyco Healthcare Group LP (US) 2010-01-06 EP disclosed
WO-2009152082-A1 HYDROXYPHENYLSULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-12-17 WO disclosed
CN-100569760-C Having beta2Compounds with adrenergic receptor agonist and muscarinic receptor antagonist activity THERAVANCE INC (US) 2009-12-16 CN disclosed
US-20090306134-A1 Muscarinic receptor antagonists THERAVANCE BIOPHARMA R&D IP, LLC 2009-12-10 US disclosed
EP-2121632-A1 4-AMINO-1H-PYRIMIDIN-2-ONE BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE Lexicon Pharmaceuticals, Inc. (US) 2009-11-25 EP disclosed
CN-101553232-A Kinase inhibitors useful for the treatment of proliferative diseases DECIPHERA PHARMACEUTICALS LLC (US) 2009-10-07 CN disclosed
CN-101535421-A Method for producing coatings with metal coordinating and film-forming materials BASF CORP (US) 2009-09-16 CN disclosed
CN-101535380-A Metal coordinating and film-forming materials BASF CORP (US) 2009-09-16 CN disclosed
WO-2009106351-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE B2 ADRENERGIC RECEPTOR ALMIRALL, S.A. (ES) 2009-09-03 WO disclosed
US-20090182010-A1 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE BIOPHARMA R&D IP, LLC 2009-07-16 US disclosed
US-20090182033-A1 Cyclic Amine Derivatives and Their Uses ARGENTA DISCOVERY LTD. (GB) 2009-07-16 US disclosed
US-7528253-B2 Compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity THERAVANCE, INC. (US) 2009-05-05 US disclosed
WO-2009043130-A1 IMPROVED SYSTEM AND MANUFACTURING PROCESS OF BIO- REPAIR OF SUBSTANCES IN THE LIQUID STATE WHICH CONTAIN CARBON MOLECULES IN ITS STRUCTURE FALNES ELINGSEN, HANS (BR) 2009-04-09 WO disclosed
WO-2009037001-A2 NOVEL TETRAHYDROFUSEDPYRIDINES AS HISTONE DEACETYLASE INHIBITORS 4SC AG (DE) 2009-03-26 WO disclosed
CN-101387823-A Photothermographic material KONICA MINOLTA MED & GRAPHIC (JP) 2009-03-18 CN disclosed
US-7504200-B2 Combined use of a lubricating silicon-containing acrylic polymer and a fluorosurfactant, such as diperfluorononyl polyethylene glycol, greatly improves wear and stain resistances KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2009-03-17 US disclosed
CN-101374803-A Cyclic amine derivatives and their uses ARGENTA DISCOVERY LTD (GB) 2009-02-25 CN disclosed
US-20090042125-A1 PHOTOTHERMOGRAPHIC MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2009-02-12 US disclosed
US-7462445-B2 Image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-12-09 US disclosed
US-7456203-B2 Muscarinic receptor antagonists THERAVANCE, INC. (US) 2008-11-25 US disclosed
US-7445884-B2 Photothermographic material, development method and thermal development device thereof KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-11-04 US disclosed
US-20080269271-A1 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders GRUENENTHAL GMBH (DE) 2008-10-30 US disclosed
EP-1971572-A1 CYCLIC AMINE DERIVATIVES AND THEIR USES Argenta Discovery Limited (GB) 2008-09-24 EP disclosed
US-7427467-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-09-23 US disclosed
US-20080214807-A1 Substituted Spiro Compounds and their Use for Producing Drugs GRUENENTHAL GMBH (DE) 2008-09-04 US disclosed
US-7419775-B2 Micro-particle dispersion having hydrophobic protective colloid and method of manufacture thereof, photosensitive emulsion and method of manufacturing thereof, and silver salt photohermographic dry imaging material utilizing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-09-02 US disclosed
WO-2008103329-A2 ELASTOMER AND VULCANIZATE COMPOSITIONS HAVING DESIRABLE HIGH TEMPERATURE PROPERTIES TEKNOR APEX COMPANY (US) 2008-08-28 WO disclosed
US-20080207832-A1 Elastomer and vulcanizate compositions having desirable high temperature properties TEKNOR APEX COMPANY 2008-08-28 US disclosed
US-20080193884-A1 Image Forming Method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-08-14 US disclosed
US-20080187875-A1 PHOTOTHERMOGRAPHIC MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-08-07 US disclosed
EP-1953592-A1 Photothermographic material Konica Minolta Medical & Graphic, Inc. (JP) 2008-08-06 EP disclosed
US-20080182847-A1 4-AMINO-1H-PYRIMIDIN-2-ONE BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE OXFORD FINANCE LLC, AS COLLATERAL AGENT 2008-07-31 US disclosed
CN-100406486-C Fluorochemical urethane composition for treatment of fibrous substrates 3M INNOVATIVE PROPERTIES CO (US) 2008-07-30 CN disclosed
EP-1945641-A1 HEPATITIS C VIRUS INHIBITORS Brystol-Myers Squibb Company (US) 2008-07-23 EP disclosed
EP-1278101-B1 Silver salt photothermographic imaging material, and image recording method and image forming method by the use thereof KONICA MINOLTA MED & GRAPHIC (JP) 2008-07-02 EP disclosed
WO-2008076778-A1 4-AMINO-1H-PYRIMIDIN-2-ONE BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS, INC. (US) 2008-06-26 WO disclosed
US-7384597-B2 Organic silver salt composition and manufacturing method thereof and photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-06-10 US disclosed
EP-1923425-A1 Thermoplastic elastomer composition Kuraray Co., Ltd. (JP) 2008-05-21 EP disclosed
US-7375227-B2 Quinoline derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2008-05-20 US disclosed
US-7364841-B2 Comprising support having thereon light-insensitive organic silver salt grains, photosensitive silver halide grains, a reducing agent for silver ions and a binder; improved storage stability, image lasting quality; use in medical diagnosis and graphic arts KONICA MINOLTA & MEDICAL GRAPHIC, INC. (JP) 2008-04-29 US disclosed
EP-1906235-A1 METHOD FOR IMAGE FORMATION Konica Minolta Medical & Graphic, Inc. (JP) 2008-04-02 EP disclosed
US-20080057447-A1 rapid thermal processing of a photothermographic materials; involving a transport feed roller, light-insensitive layer or back coating layer contains a lubricant fatty ester, a biphenol derivatives reducing agent for silver KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2008-03-06 US disclosed
US-7335665-B2 Spirocyclic piperidines as MCH1 antagonists and uses thereof H - LUNDBECK A/S (DK) 2008-02-26 US disclosed
US-7335466-B2 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2008-02-26 US disclosed
US-7326527-B2 Silver salt photothermographic dry imaging material and image forming method by use thereof KONICA MINOLTA MEDICAL & GRAPHIC, INC (JP) 2008-02-05 US disclosed
US-20080009543-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2008-01-10 US disclosed
US-7309565-B2 Process for treating photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-12-18 US disclosed
US-20070282078-A1 Synthesis of aryl N-acylurea from aryl isocyanates or aryl carbodiimides for use as intermediate in novel sequential self-repetitive reaction (SSRR) to form amides, amide-imides and their polymers NATIONAL CHUNG HSING UNIVERSITY (TW) 2007-12-06 US disclosed
EP-1209212-B1 ADHESIVE COMPOSITION AND METHOD OF BONDING WITH THE ADHESIVE COMPOSITION SEKISUI CHEMICAL CO LTD (JP) 2007-11-14 EP disclosed
US-7285563-B2 Heteroaromatic urea derivatives as VR-1 receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2007-10-23 US disclosed
EP-1844052-A1 THIENO[2,3-D]PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION Pharmacia & Upjohn Company LLC (US) 2007-10-17 EP disclosed
US-7270945-B2 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-09-18 US disclosed
US-7267934-B2 Method of forming an image KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-09-11 US disclosed
US-20070202447-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL AND IMAGE FORMING METHOD BY USE THEREOF KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-08-30 US disclosed
EP-1684115-B1 Photothermographic material KONICA MINOLTA MED & GRAPHIC (JP) 2007-08-08 EP disclosed
CN-1326943-C Two-component polyurethane adhesive for structural finger joint and method therefor ASHLAND ADMISSION AND INTELLEC (US) 2007-07-18 CN disclosed
US-7244845-B2 Process for preparing cyclic N-substituted alpha-imino carboxylic acids SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-07-17 US disclosed
US-20070155835-A1 USE OF ORTHO-PHENYLPHENOL AND/OR DERIVATIVES THEREOF FOR INHIBITING THE ASEXUAL REPRODUCTION OF FUNGI HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2007-07-05 US disclosed
CN-1989164-A Curable composition THREE BOND CO LTD (JP) 2007-06-27 CN disclosed
WO-2007068929-A1 CYCLIC AMINE DERIVATIVES AND THEIR USES ARGENTA DISCOVERY LTD. (GB) 2007-06-21 WO disclosed
US-20070135423-A1 E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain MERCK SHARP & DOHME LTD. (GB) 2007-06-14 US disclosed
US-7229752-B2 Nonaqueous dispersion of particles insoluble in solvent; mixture containing metal complex as dopant KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-06-12 US disclosed
US-7220536-B2 Silver salt photothermographic dry imaging material, thermal development method of the same, and thermal development apparatus for the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-22 US disclosed
US-20070105059-A1 IMAGE FORMING METHOD USING PHOTOTHERMOGRAPHIC MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-10 US disclosed
US-20070099955-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2007-05-03 US disclosed
EP-1778626-A1 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance, Inc. (US) 2007-05-02 EP disclosed
US-20070093414-A1 Hepatitis C virus inhibitors BRISTOL-MYERS SQUIBB COMPANY 2007-04-26 US disclosed
CN-1951712-A Run flat tire support and colorant thereof DOW GLOBAL TECHNOLOGIES INC (US) 2007-04-25 CN disclosed
WO-2007044933-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-04-19 WO disclosed
US-20070082300-A1 Image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-04-12 US disclosed
US-7202019-B2 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. (JP) 2007-04-10 US disclosed
CN-1308391-C Thermally Crosslinkable Resin Dispersion SANYO CHEMICAL IND LTD (JP) 2007-04-04 CN disclosed
US-7192696-B2 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-03-20 US disclosed
US-20070054225-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-03-08 US disclosed
WO-2006083317-A9 PEPTIDE ANTIBIOTICS AND METHODS FOR MAKING SAME BIOSOURCE PHARM INC (US) 2007-03-01 WO disclosed
US-20070039499-A1 PROCESS FOR TREATING PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-02-22 US disclosed
US-20070043080-A1 Substituted anilinic piperidines as MCH selective antagonists MARZABADI MOHAMMAD R 2007-02-22 US disclosed
US-7175978-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-02-13 US disclosed
EP-1749001-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS Aventis Pharmaceuticals, Inc. (US) 2007-02-07 EP disclosed
WO-2007012661-A1 HYDANTOIN DERIVED COMPOUNDS AND USE THEREOF AS MCHR-1 ANTAGONISTS CEREP (FR) 2007-02-01 WO disclosed
US-20070012569-A1 Cationic electrodeposition coating composition NIPPON PAINT CO., LTD. (JP) 2007-01-18 US disclosed
CN-1295087-C Run-flat tire support and colorant therefor DOW GLOBLE TECHNOLOGY COMPANY (US) 2007-01-17 CN disclosed
US-7163782-B2 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. (JP) 2007-01-16 US disclosed
EP-1521583-B1 7,8,9,10-TETRAHYDRO-6H-AZEPINO, 6,7,8,9-TETRAHYDRO-PYRIDO AND 2,3-DIHYDRO-2H-PYRROLO (2,1-B)-QUINAZOLINONE DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2007-01-10 EP disclosed
US-20070003886-A1 SILVER SALT PHOTOTHERMOGRAPHIC DRY IMAGING MATERIAL KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-01-04 US disclosed
CN-1890359-A Adhesion inhibition of micro organisms by non-ionic surfactants HENKEL KGAA (DE) 2007-01-03 CN disclosed
US-7153645-B2 Silver salt photo-thermal photographic dry imaging material, an image recording method and an image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-12-26 US disclosed
CN-1882556-A Having beta2Compounds with adrenergic receptor agonist and muscarinic receptor antagonist activity THERAVANCE INC (US) 2006-12-20 CN disclosed
US-7150964-B2 Process for treating photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-12-19 US disclosed
CN-1874775-A 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (VR1) for the treatment of pain MERCK SHARP & DOHME (GB) 2006-12-06 CN disclosed
US-7144694-B2 Photothermographic imaging material and method for forming image KONICA MINOLTA HOLDINGS, INC. (JP) 2006-12-05 US disclosed
US-7138225-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-11-21 US disclosed
US-20060257281-A1 Adhesion inhibition of microorganisms by non-ionic surfactants HENKEL AG & CO KGAA (DE) 2006-11-16 US disclosed
US-7132227-B2 Silver salt photothermographic dry imaging material and image recording method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-11-07 US disclosed
EP-1717635-A1 Silver salt photothermographic dry imaging material Konica Minolta Medical & Graphic Inc. (JP) 2006-11-02 EP disclosed
US-7129030-B2 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-10-31 US disclosed
US-20060240367-A1 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2006-10-26 US disclosed
CN-1279395-C Liquid crystal aligning agent, liquid crystal cell using the same, and method for aligning liquid crystal NISSAN CHEMICAL IND LTD (JP) 2006-10-11 CN disclosed
US-20060216657-A1 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2006-09-28 US disclosed
US-20060211707-A1 Piperazine-alkyl-ureido derivatives ACTELION PHARMACEUTICALS LTD. (CH) 2006-09-21 US disclosed
US-20060210935-A1 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. 2006-09-21 US disclosed
CN-1826322-A Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT 2A serotonin receptor for the prevention and treatment of related disorders ARENA PHARM INC (US) 2006-08-30 CN disclosed
US-7097962-B2 Silver salt photothermographic dry imaging material KONICA MINOLTN MEDICAL & GRAPHIC, INC. (JP) 2006-08-29 US disclosed
US-7094526-B2 Silver salt photothermographic dry imaging material and production method of the same KONICA MINOLTA MEDICAL & GRAPHIC, INC (JP) 2006-08-22 US disclosed
US-20060177783-A1 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. 2006-08-10 US disclosed
US-7087367-B2 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC (JP) 2006-08-08 US disclosed
US-7087368-B1 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2006-08-08 US disclosed
WO-2006079916-A1 THIENO [2,3-D] PYRIMIDINE COMPOUNDS AS INHIBITORS OF ADP-MEDIATED PLATELETS AGGREGATION PHARMACIA & UPJOHN COMPANY LLC (US) 2006-08-03 WO disclosed
US-20060172236-A1 Silver salt photothermographic dry imaging material and image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-08-03 US disclosed
US-20060172233-A1 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. 2006-08-03 US disclosed
US-20060173027-A1 Spirocvclic piperidines as mch1 antagonists and uses thereof H. LUNDBECK A/S (DK) 2006-08-03 US disclosed
CN-1812713-A Inhibition of the asexual reproduction of fungi HENKEL KGAA (DE) 2006-08-02 CN disclosed
US-20060166150-A1 Photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-07-27 US disclosed
EP-1682141-A1 4-FLUORO-4-(PYRIDIN-2-YL)-PIPERIDINE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) FOR THE TREATMENT OF PAIN MERCK SHARP & DOHME LTD. (GB) 2006-07-26 EP disclosed
EP-1684115-A1 Photothermographic material Konica Minolta Medical & Graphic, Inc. (JP) 2006-07-26 EP disclosed
US-7074855-B2 Thermoplastic elastomer composition KURARAY CO., LTD. (JP) 2006-07-11 US disclosed
CN-1261312-C Run flat tire support DOW GLOBLE TECHNOLOGY COMPANY (US) 2006-06-28 CN disclosed
US-7067519-B2 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives ACTELION PHARMACEUTICALS, LTD. (CH) 2006-06-27 US disclosed
US-7067534-B1 Substituted anilinic piperidines as MCH selective antagonists H. LUNDBECK A/S (DK) 2006-06-27 US disclosed
US-20060130702-A1 Inhibition of the asexual reproduction of fungi HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2006-06-22 US disclosed
CN-1260076-C Run flat tire support DOW CHEMICAL CO (US) 2006-06-21 CN disclosed
CN-1784395-A Piperazine-alkyl-ureido derivatives ACTELION PHARMACEUTICALS LTD (CH) 2006-06-07 CN disclosed
US-20060116398-A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity THERAVANCE BIOPHARMA R&D IP, LLC 2006-06-01 US disclosed
CN-1780884-A Cathodic corrosion protection powder coating compositions and methods DU PONT (US) 2006-05-31 CN disclosed
US-20060099539-A1 Micro-particle dispersion having hydrophobic protective colloid and method of manufacture thereof, photosensitive emulsion and method of manufacturing thereof, and silver salt photohermographic dry imaging material utilizing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2006-05-11 US disclosed
US-20060088785-A1 Silver salt photothermographic dry imaging material, thermal development method of the same, and thermal development apparatus for the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-04-27 US disclosed
US-20060084016-A1 Photosensitive layer having silver behenate, silver halide, reducing agent and binder; and a cyan coloring leuco dye derivative of P,P*-methylenediphenol or bis/P-hydroxyphenyl/sulfide; high density; light radiated image stability and silver color tone; heat resistance KONICA MINOLTA HOLDINGS, INC. 2006-04-20 US disclosed
EP-1422552-B1 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS INC (JP) 2006-04-12 EP disclosed
US-7018790-B2 Photothermographic imaging material and method for forming image KONICA MINOLTA HOLDINGS, INC. (JP) 2006-03-28 US disclosed
US-20060057513-A1 Organic silver salt composition and manufacturing method thereof and photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2006-03-16 US disclosed
EP-1631565-A1 PIPERAZINE-ALKYL-UREIDO DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2006-03-08 EP disclosed
WO-2006023457-A1 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE, INC. (US) 2006-03-02 WO disclosed
US-7005251-B2 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2006-02-28 US disclosed
US-20060029892-A1 Nonaqueous dispersion of particles insoluble in solvent; mixture containing metal complex as dopant KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2006-02-09 US disclosed
US-20060014111-A1 Method of forming an image KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-01-19 US disclosed
US-20060003272-A1 Photothermographic material, development method and thermal development device thereof KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2006-01-05 US disclosed
CN-1717408-A Carbamic acid esters with anticholinergic activity BOEHRINGER INGELHEIM PHARMA (DE) 2006-01-04 CN disclosed
EP-1531816-A4 SPIROCYCLIC PIPERIDINES AS MCH1 ANTAGONISTS AND USES THEREOF LUNDBECK & CO AS H (DK) 2005-12-28 EP disclosed
US-20050282095-A1 Silver salt photothermographic dry imaging material and image recording method KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-12-22 US disclosed
EP-1241520-B1 Silver salt photothermographic dry imaging material and image recording method thereof KONISHIROKU PHOTO IND (JP) 2005-12-21 EP disclosed
EP-1607797-A1 Silver salt photothermographic dry imaging material and image recording method Konica Minolta Medical & Graphic Inc. (JP) 2005-12-21 EP disclosed
US-6974500-B2 Promoting a longer open time, with an isocyanate compound having silanol group, which can be hydrolysis, reacting to isocyanate group in adhesives; storage stability and adhesiveness THE YOKOHAMA RUBBER CO., LTD. (JP) 2005-12-13 US disclosed
US-20050271986-A1 Process for treating photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-12-08 US disclosed
EP-1499607-B1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2005-12-07 EP disclosed
US-20050267150-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C 2005-12-01 US disclosed
WO-2005111025-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS AVENTIS PHARMACEUTICALS INC. (US) 2005-11-24 WO disclosed
US-20050250057-A1 Image forming method using photothermographic material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-11-10 US disclosed
US-20050234090-A1 Modulators of chemokine receptor activity PFIZER INC 2005-10-20 US disclosed
CN-1671386-A Substituted anilinic piperidines as MCH selective antagonists LUNDBECK & CO AS H (DK) 2005-09-21 CN disclosed
US-20050192269-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2005-09-01 US disclosed
US-20050192265-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2005-09-01 US disclosed
CN-1215371-C Silver salt light heat sensitive imaging material and image recording method and imaging method using such material KONISHIROKU PHOTO IND (JP) 2005-08-17 CN disclosed
US-20050170300-A1 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-08-04 US disclosed
CN-1646624-A Thermocrosslinkable resin dispersion SANYO CHEMICAL IND LTD (JP) 2005-07-27 CN disclosed
US-20050158676-A1 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-07-21 US disclosed
US-20050131231-A1 Process for preparing cyclic N-substituted alpha-imino carboxlic acids AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2005-06-16 US disclosed
CN-1628153-A Two-part polyurethane adhesives for structural finger joints and method therefor ASHLAND INC (US) 2005-06-15 CN disclosed
US-6906056-B2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds ELAN PHARMACEUTICALS, INC. (US) 2005-06-14 US disclosed
WO-2005051390-A1 E-FLUORO-4-(PYRIDIN-2-YL)-PIPERIDINE-1-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1) FOR THE TREATMENT OF PAIN MERCK SHARP & DOHME LIMITED (GB) 2005-06-09 WO disclosed
US-20050113414-A1 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens CELLTECH R&D LIMITED (GB) 2005-05-26 US disclosed
EP-1531816-A1 SPIROCYCLIC PIPERIDINES AS MCH1 ANTAGONISTS AND USES THEREOF H. Lundbeck A/S (DK) 2005-05-25 EP disclosed
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain MERCK SHARP & DOHME LTD. (GB) 2005-05-19 US disclosed
US-20050107456-A1 Substituted pyrazolines for use as pesticides BAYER CROPSCIENCE AG (DE) 2005-05-19 US disclosed
CN-1202081-C Amidino and guanidino beta-azetidinone tryptase inhibitors BRISTOL MYERS SQUIBB CO (US) 2005-05-18 CN disclosed
US-6894063-B2 Substituted urea neuropeptide Y Y5 Receptor antagonists SCHERING CORPORATION (US) 2005-05-17 US disclosed
EP-1530079-A1 Silver salt photothermographic dry imaging material Konica Minolta Medical & Graphic, Inc. (JP) 2005-05-11 EP disclosed
US-20050095541-A1 Silver salt photothermographic dry imaging material and production method of the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. 2005-05-05 US disclosed
US-20050089807-A1 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2005-04-28 US disclosed
CN-1610710-A Fluorochemical urethane composition for treatment of fibrous substrates 3M INNOVATIVE PROPERTIES CO (US) 2005-04-27 CN disclosed
EP-1521583-A1 7,8,9,10-TETRAHYDRO-6H-AZEPINO, 6,7,8,9-TETRAHYDRO-PYRIDO AND 2,3-DIHYDRO-2H-PYRROLO (2,1-B)-QUINAZOLINONE DERIVATIVES Actelion Pharmaceuticals Ltd. (CH) 2005-04-13 EP disclosed
EP-1519223-A1 Silver salt photothermographic dry imaging material Konica Minolta Medical & Graphic Inc. (JP) 2005-03-30 EP disclosed
US-20050064352-A1 Silver salt photothermographic dry imaging material KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2005-03-24 US disclosed
US-20050043535-A1 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists ACTELION PHARMACEUTICALS LTD. (CH) 2005-02-24 US disclosed
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines TRIAD THERAPEUTICS, INC. 2005-02-24 US disclosed
CN-1585633-A Phenylethanolamine derivatives for the treatment of respiratory diseases GLAXO GROUP LTD (GB) 2005-02-23 CN disclosed
US-20050038100-A1 Substituted urea neuropeptide Y Y5 receptor antagonists GREENLEE WILLIAM J (US) 2005-02-17 US disclosed
US-20050032010-A1 Silver salt photo-thermal photographic dry imaging material, an image recording method and an image forming method KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2005-02-10 US disclosed
EP-1505436-A1 A silver salt photothermographic dry imaging material Konica Minolta Medical & Graphic, Inc. (JP) 2005-02-09 EP disclosed
US-20050019825-A9 Common ligand mimics: pseudothiohydantoins TRIAD THERAPEUTICS, INC. 2005-01-27 US disclosed
EP-1499607-A1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO)-QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS Actelion Pharmaceuticals Ltd. (CH) 2005-01-26 EP disclosed
EP-1411942-A4 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMA CORP (US) 2005-01-26 EP disclosed
US-20050009852-A1 7 8 9 10-tetrahydro-6h-azepino, 6 7 8 9-tetrahydro-pyrido and 2 3-dihydro-2h-pyrrolo[2 1-b]-quinazolinone derivates ACTELION PHARMACEUTICALS, LTD. (CH) 2005-01-13 US disclosed
EP-1490340-A1 HETEROAROMATIC UREA DERIVATIVES AS VR-1 RECEPTOR MODULATORS FOR TREATING PAIN MERCK SHARP & DOHME LTD. (GB) 2004-12-29 EP disclosed
CN-1556705-A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives ������˹ҩƷ��˾ 2004-12-22 CN disclosed
EP-1478359-A1 PIPERIDIN-4-YL UREA DERIVATIVES AND RELATED COMPOUNDS AS CHEMOKINE RECEPTOR INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Celltech R & D Limited (GB) 2004-11-24 EP disclosed
CN-1549714-A Aminoisoxazole derivatives active as kinase inhibitors 2004-11-24 CN disclosed
US-6821964-B2 FOR PROPHYLAXIS AND THERAPY OF DISEASES ASSOCIATED WITH MONOCYTE ACCUMULATION, LYMPHOCYTE ACCUMULATION OR LEUCOCYTE ACCUMULATION PFIZER INC 2004-11-23 US disclosed
WO-2004099179-A1 PIPERAZINE-ALKYL-UREIDO DERIVATIVES ACTELION PHARMACEUTICALS LTD (CH) 2004-11-18 WO disclosed
US-20040229175-A1 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. 2004-11-18 US disclosed
US-20040209928-A1 Glucagon receptor antagonists/inverse agonists ABBOTT LABORATORIES 2004-10-21 US disclosed
WO-2004063150-A2 DIAGNOSTIC AND THERAPEUTIC ALKYL PIPERIDINE/PIPERAZINE COMPOUNDS AND PROCESS THE GENERAL HOSPITAL CORPORATION (US) 2004-07-29 WO disclosed
US-20040132907-A1 Thermoplastic elastomer composition KURARAY CO., LTD. (JP) 2004-07-08 US disclosed
US-20040115569-A1 Photothermographic imaging material and method for forming image KONICA MINOLTA HOLDINGS, INC. (JP) 2004-06-17 US disclosed
US-20040110229-A1 Muscarinic receptor antagonists PNC BANK, NATIONAL ASSOCIATION 2004-06-10 US disclosed
US-20040106074-A1 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2004-06-03 US disclosed
US-20040106598-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds THOMPSON RICHARD C (US) 2004-06-03 US disclosed
US-20040101794-A1 Photothermographic imaging material KONICA MINOLTA HOLDINGS, INC. (JP) 2004-05-27 US disclosed
EP-1422552-A2 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2004-05-26 EP disclosed
EP-1411942-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS Synaptic Pharmaceutical Corporation (US) 2004-04-28 EP disclosed
US-6727264-B1 MELANIN CONCENTRATING HORMONE-1 RECEPTOR ANTAGONISTS; SLEEP, EATING, SEXUAL DISORDERS SYNAPTIC PHARMACEUTICAL CORPORATION 2004-04-27 US disclosed
EP-1398349-A1 THERMOPLASTIC ELASTOMER COMPOSITION Kuraray Co., Ltd. (JP) 2004-03-17 EP disclosed
US-20040043338-A1 Thermally developable photosensitive material and image forming method KONICA CORPORATION (JP) 2004-03-04 US disclosed
US-6699649-B2 TO BE EFFECTIVELY EXPOSED EMPLOYING LASER IMAGERS AND LASER IMAGE SETTERS, AND CAN FORM CLEAR BLACK-AND-WHITE IMAGES EXHIBITING HIGH RESOLUTION KONICA CORPORATION (JP) 2004-03-02 US disclosed
US-20040039113-A1 Primer composition YOKOHAMA RUBBER CO., LTD. (JP) 2004-02-26 US disclosed
US-6693202-B1 MULTIBINDING LIGANDS CONTAINING SUCH AS AMINE, AMIDE, ESTER, HYDROXYL, CARBAMATE, UREA AND/OR IMINO FUNCTIONALITY THERAVANCE, INC. 2004-02-17 US disclosed
CN-1474810-A Substituted urea neuropeptide YY5 antagonists ���鹫˾ 2004-02-11 CN disclosed
WO-2004004714-A1 SPIROCYCLIC PIPERIDINES AS MCH1 ANTAGONISTS AND USES THEREOF H. LUNDBECK A/S (DK) 2004-01-15 WO disclosed
WO-2004004733-A1 7,8,9,10-TETRAHYDRO-6H-AZEPINO, 6,7,8,9-TETRAHYDRO-PYRIDO AND 2,3-DIHYDRO-2H-PYRROLO[2,1-B]-QUINAZOLINONE DERIVATIVES ACTELION PHARMACEUTICALS LTD. (CH) 2004-01-15 WO disclosed
CN-1464848-A Run flat tire support DOW CHEMICAL CO (US) 2003-12-31 CN disclosed
EP-1368354-A1 MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Pfizer Products Inc. (US) 2003-12-10 EP disclosed
US-6653295-B2 Protease inhibitor; viricide BRISTOL-MYERS SQUIBB COMPANY 2003-11-25 US disclosed
CN-1455745-A Run flat tire support DOW GLOBLE TECHNOLOGY COMPANY (US) 2003-11-12 CN disclosed
CN-1455744-A Run-flat tire support and colorant therefor DOW GLOBLE TECHNOLOGY COMPANY (US) 2003-11-12 CN disclosed
US-6642305-B2 For use in coating or adhesive formulation AKZO NOBEL N.V. (NL) 2003-11-04 US disclosed
US-20030203323-A1 Silver salt photothermographic dry imaging material and image recording method as well as image forming method using the same KONICA CORPORATION (JP) 2003-10-30 US disclosed
US-20030194658-A1 Silver salt photothermographic imaging material, and image recording method and image forming method by theuse thereof KONICA CORPORATION (JP) 2003-10-16 US disclosed
WO-2003080578-A1 HETEROAROMATIC UREA DERIVATIVES AS VR-1 RECEPTOR MODULATORS FOR TREATING PAIN MERCK SHARP & DOHME LIMITED (GB) 2003-10-02 WO disclosed
EP-1345075-A2 Silver salt photothermographic dry imaging material and image recording method as well as image forming method using the same KONICA CORPORATION (JP) 2003-09-17 EP disclosed
WO-2003070242-A1 PIPERIDIN-4-YL UREA DERIVATIVES AND RELATED COMPOUNDS AS CHEMOKINE RECEPTOR INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES CELLTECH R & D LIMITED (GB) 2003-08-28 WO disclosed
EP-1322628-A2 SUBSTITUTED UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2003-07-02 EP disclosed
US-20030114517-A1 Substituted urea neuropeptide Y Y5 receptor antagonists SCHERING CORPORATION 2003-06-19 US disclosed
WO-2003048154-A1 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO) -QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS ACTELION PHARMACEUTICALS LTD (CH) 2003-06-12 WO disclosed
CN-1420170-A Method for producing formed grain for immobilization of enzyme or microbiologic cell KANSAI PAINT CO LTD (JP) 2003-05-28 CN disclosed
US-6569851-B1 Treating Alzheimer's disease ELAN PHARMACEUTIALS, INC. 2003-05-27 US disclosed
EP-0957400-B1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING PATTERN THEREFROM, ELECTRONIC DEVICES PRODUCED BY USING THE SAME, AND METHOD FOR PRODUCTION THEREOF HITACHI CHEMICAL CO LTD (JP) 2003-04-16 EP disclosed
US-6548539-B1 Aliphatic cyclic or heterocyclic compounds substituted with amido or urea groups and either ether or sulfide groups; treating cancer, cardiovascular disorders, skin disorders, osteoporosis, and arthritis AVALON PHARMACEUTICALS 2003-04-15 US disclosed
US-20030064962-A1 Inhibitors of hepatitis C virus NS3 protease BRISTOL-MYERS SQUIBB COMPANY (FORMERLY D/B/A DUPONT PHARMACEUTICALS COMPANY) 2003-04-03 US disclosed
US-6534251-B1 Comprises silver behenate; photosensitivity; exhibits enhanced sensitivity, minimized fogging, and storage stability; for laser imaging in medical diagnosis and printing plates KONICA CORPORATION (JP) 2003-03-18 US disclosed
US-20030039927-A1 Silver salt photothermographic dry imaging material and image recording method thereof KONICA CORPORATION (JP) 2003-02-27 US disclosed
CN-1397838-A Silver salt light heat sensitive imaging material and image recording method and imaging method using such material KONISHIROKU PHOTO IND (JP) 2003-02-19 CN disclosed
CN-1393737-A Heat developing photo sensitive material KONISHIROKU PHOTO IND (JP) 2003-01-29 CN disclosed
EP-1278101-A2 Silver salt photothermographic imaging material, and image recording method and image forming method by the use thereof KONICA CORPORATION (JP) 2003-01-22 EP disclosed
WO-2003004027-A1 SUBSTITUTED ANILINIC PIPERIDINES AS MCH SELECTIVE ANTAGONISTS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2003-01-16 WO disclosed
US-20030008893-A1 Modulators of chemokine receptor activity COLON-CRUZ ROBERTO (US) 2003-01-09 US disclosed
US-20020165223-A1 Substituted urea neuropeptide Y Y5 receptor antagonists SCHERING CORPORATION 2002-11-07 US disclosed
EP-1241520-A2 Silver salt photothermographic dry imaging material and image recording method thereof KONICA CORPORATION (JP) 2002-09-18 EP disclosed
WO-2002070523-A1 MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY PFIZER PRODUCTS INC. (US) 2002-09-12 WO disclosed
CN-1090665-C Magnetic recording binder containing aminoalkylphosphonate salt MORTON INT INC (US) 2002-09-11 CN disclosed
EP-0860433-B1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF GROWTH FACTOR RECEPTOR ORIGINATING IN PLATELET AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KIRIN BREWERY (JP) 2002-07-03 EP disclosed
US-20020082324-A1 For use in coating or adhesive formulation ALLNEX NETHERLANDS B.V. (NL) 2002-06-27 US disclosed
WO-2002048116-A2 INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-06-20 WO disclosed
EP-1209212-A1 ADHESIVE COMPOSITION AND METHOD OF BONDING WITH THE ADHESIVE COMPOSITION SEKISUI CHEMICAL CO., LTD. (JP) 2002-05-29 EP disclosed
WO-2002022592-A2 SUBSTITUTED UREA NEUROPEPTIDE Y Y5 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 2002-03-21 WO disclosed
US-6335324-B1 TREATING ASTHMA OR ALLERGIC RHINITIS BRISTOL-MYERS SQUIBB CO. 2002-01-01 US disclosed
EP-1089973-A4 AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2001-12-12 EP disclosed
CN-1075103-C Polyurethane adhesives/sealant composition, precursor and preparation process thereof AOBO ADHESIVE CHEMICAL CO LTD (CN) 2001-11-21 CN disclosed
CN-1319198-A Liquid crystal aligning agent, liquid crystal cell using the same, and method for aligning liquid crystal NISSAN CHEMICAL IND LTD (JP) 2001-10-24 CN disclosed
US-6291619-B1 HEAT RESISTANCE HITACHI CHEMICAL CO., LTD (JP) 2001-09-18 US disclosed
CN-1307560-A Amidino and guanidino beta-azetidinone tryptase inhibitors BRISTOL MYERS SQUIBB CO (US) 2001-08-08 CN disclosed
EP-1089980-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS Elan Pharmaceuticals, Inc. (US) 2001-04-11 EP disclosed
EP-1089973-A1 AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-04-11 EP disclosed
CN-1061074-C Polyurethane pressure-sensitive adhesives SQUIBB & SONS INC (US) 2001-01-24 CN disclosed
US-6143764-A ETHER DERIVATIVES OF QUINOLINE, ANTITUMOR AGENTS KIRIN BEER KABUSHIKI KAISHA (JP) 2000-11-07 US disclosed
WO-2000037520-A1 THIXOTROPIC AMINO FORMALDEHYDE RESIN AKZO NOBEL N.V. (NL) 2000-06-29 WO disclosed
CN-1251600-A Unsaturated Polymer Polyurethane Structural Adhesives ASHLAND INC (US) 2000-04-26 CN disclosed
CN-1248606-A Polyurethane adhesives/sealant composition, precursor and preparation process thereof AOBO ADHEIVE CHEMICAL CO LTD S (CN) 2000-03-29 CN disclosed
CN-1242689-A Pesticide composition HAMPSHIRE CHEMICAL CORP (US) 2000-01-26 CN disclosed
WO-1999067215-A1 AMIDINO AND GUANIDINO AZETIDINONE TRYPTASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-12-29 WO disclosed
WO-1999067221-A1 COMPOUNDS FOR INHIBITING BETA-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS ELAN PHARMACEUTICALS, INC. (US) 1999-12-29 WO disclosed
EP-0957400-A1 PHOTOSENSITIVE RESIN COMPOSITION, METHOD FOR PRODUCING PATTERN THEREFROM, ELECTRONIC DEVICES PRODUCED BY USING THE SAME, AND METHOD FOR PRODUCTION THEREOF HITACHI CHEMICAL CO., LTD. (JP) 1999-11-17 EP disclosed
US-5963360-A Nonlinear optical element and process for the preparation of same FUJI XEROX CO., LTD. (JP) 1999-10-05 US disclosed
US-5824240-A Nonlinear optical element and process for the preparation of same FUJI XEROX CO. LTD. (JP) 1998-10-20 US disclosed
EP-0860433-A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF GROWTH FACTOR RECEPTOR ORIGINATING IN PLATELET AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME KIRIN BEER KABUSHIKI KAISHA (JP) 1998-08-26 EP disclosed
CN-1113513-A Magnetic recording binder containing aminoalkylphosphonate salt MORTON INT INC (US) 1995-12-20 CN disclosed
CN-1103098-A Polyurethane pressure-sensitive adhesives SQUIBB & SONS INC (US) 1995-05-31 CN disclosed
EP-0279376-B1 Process for producing polyurea resin IHARA CHEMICAL IND CO (JP) 1993-11-03 EP disclosed
EP-0135741-B1 COATING RESIN COMPOSITION DAINIPPON INK AND CHEMICALS, INC. (JP) 1989-06-28 EP disclosed
US-4798755-A SULFONATED, EPOXIDIZED VINYL CHLORIDE RESIN, POLYURETHANE FUJI PHOTO FILM CO., LTD. (JP) 1989-01-17 US disclosed
US-4533716-A TRIAZINE RESIN AND A POLYISOCYANATE DAINIPPON INK AND CHEMICALS, INC. (JP) 1985-08-06 US disclosed
EP-0135741-A2 Coating resin composition DAINIPPON INK AND CHEMICALS, INC. (JP) 1985-04-03 EP disclosed
EP-0019349-B1 STABILIZING COMPOSITION FOR POLYARYLENE ESTERS, STABILIZED POLYARYLENE ESTER, MOULDED ARTICLE PRODUCED THEREFROM AND PROCESS FOR STABILIZING A POLYARYLENE ESTER MONSANTO COMPANY (US) 1983-08-03 EP disclosed
US-4368237-A ORGANIC SOLVENT-FREE FUJI PHOTO FILM CO., LTD. (JP) 1983-01-11 US disclosed
US-4336308-A Magnetic recording media FUJI PHOTO FILM CO., LTD. (JP) 1982-06-22 US disclosed
US-4333988-A POLYURETHANES, CHLOROACRYLONITRILE POLYMERS FUJI PHOTO FILM CO., LTD. (JP) 1982-06-08 US disclosed
EP-0019349-A1 Stabilizing composition for polyarylene esters, stabilized polyarylene ester, moulded article produced therefrom and process for stabilizing a polyarylene ester MONSANTO COMPANY (US) 1980-11-26 EP disclosed
US-4222932-A MOLDING MATERIALS STABILIZED BY ADDING AN AROMATIC ISOCYANATE AND AN ALIPHATIC PHOSPHITE MONSANTO COMPANY (US) 1980-09-16 US disclosed
US-4188489-A Process for the production of 3-substituted amino-5-pyrazolones FUJI PHOTO FILM CO., LTD. (JP) 1980-02-12 US disclosed
US-4077937-A ACETYLENIC CARBAMATE AS CROSSLINKING INHIBITOR SHIN-ETSU CHEMICAL CO., LTD. (JA) 1978-03-07 US disclosed
US-4072712-A FROM ISOCYANATES, CATALYSIS BAYER AKTIENGESELLSCHAFT (DT) 1978-02-07 US disclosed
US-4049871-A POLYURETHANE, ALKYD RESIN, POLYISOCYANATE BINDER FUJI PHOTO FILM CO., LTD. (JA) 1977-09-20 US disclosed
US-4049871-A POLYURETHANE, ALKYD RESIN, POLYISOCYANATE BINDER FUJI PHOTO FILM CO., LTD. (JA) 1977-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009543-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION CNR1, CNR2, GPR18 ALDH1A1 3274/4885CYP1A2 830/4885MAPT 3072/4885
US-20050113414-A1 1-[1-((E)-1-Cyclooct-1-enyl)methylpiperidin-4-yl]-3-(3,4-dichlorophenyl)-urea; potent and selective modulators of CXCR3, a chemokine receptor; antagonists; treatment of conditions involving inappropriate T-cell trafficking; antiinflammatory, -arthritic agents, autoimmune diseases; antiallergens CXCR3, ACKR3, CCR1 ALDH1A1 1239/4885CYP1A2 3169/4885MAPT 1505/4885
US-20050019825-A9 Common ligand mimics: pseudothiohydantoins FGFR3, BID, FLT3 ALDH1A1 3114/4885CYP1A2 2423/4885MAPT 3613/4885
US-10407449-B1 Flame retardant, precursor thereof, and flame retardant material FFAR1, FFAR3, FFAR2 ALDH1A1 1121/4885CYP1A2 297/4885MAPT 2772/4885
US-20020165223-A1 Substituted urea neuropeptide Y Y5 receptor antagonists NPY5R, NPY1R, NPY2R ALDH1A1 4388/4885CYP1A2 3421/4885MAPT 4189/4885
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS LTA4H, EPHX2, EPHX1 ALDH1A1 450/4885CYP1A2 2292/4885MAPT 1418/4885
US-20050267150-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds BACE1, APP, BACE2 ALDH1A1 3776/4885CYP1A2 3219/4885MAPT 35/4885
US-20210253535-A1 INHIBITION OF OLIG2 ACTIVITY GLI2, ING2, GMFG ALDH1A1 1478/4885CYP1A2 4415/4885MAPT 1722/4885
US-20030114517-A1 Substituted urea neuropeptide Y Y5 receptor antagonists NPY5R, NPY1R, NPY2R ALDH1A1 4866/4885CYP1A2 4808/4885MAPT 1445/4885
US-20050131231-A1 Process for preparing cyclic N-substituted alpha-imino carboxlic acids MMP1, MMP2, MMP9 ALDH1A1 292/4885CYP1A2 678/4885MAPT 4736/4885
US-20070043080-A1 Substituted anilinic piperidines as MCH selective antagonists MCHR1, MCHR2, MC1R ALDH1A1 620/4885CYP1A2 503/4885MAPT 2336/4885
US-20080214807-A1 Substituted Spiro Compounds and their Use for Producing Drugs REN, PKD1, NR3C2 ALDH1A1 281/4885CYP1A2 138/4885MAPT 3811/4885
US-20050009852-A1 7 8 9 10-tetrahydro-6h-azepino, 6 7 8 9-tetrahydro-pyrido and 2 3-dihydro-2h-pyrrolo[2 1-b]-quinazolinone derivates HCRTR2, HCRTR1, NPY1R ALDH1A1 1416/4885CYP1A2 429/4885MAPT 2059/4885
US-20100137402-A1 N-[(4,5-DIPHENYL-2-THIENYL)METHYL]AMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION CNR1, CNR2, GPR18 ALDH1A1 3274/4885CYP1A2 830/4885MAPT 3072/4885
US-20090182010-A1 COMPOUNDS HAVING BETA2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY ADRB2, ADRA2B, ADRA2A ALDH1A1 1147/4885CYP1A2 368/4885MAPT 2962/4885
US-20040110229-A1 Muscarinic receptor antagonists CHRM3, CHRM5, CHRM2 ALDH1A1 2335/4885CYP1A2 2058/4885MAPT 3022/4885
US-20110021494-A1 NOVEL TETRAHYDRO-FUSED PYRIDINES AS HISTONE DEACETYLASE INHIBITORS HDAC1, HDAC11, HDAC3 ALDH1A1 912/4885CYP1A2 2147/4885MAPT 2144/4885
US-20050043535-A1 4-(Piperidyl-and pyrrolidyl-alkyl-ureido)-quinolines as urotensin II receptor antagonists UTS2R, NTSR2, PLAUR ALDH1A1 2993/4885CYP1A2 1788/4885MAPT 941/4885
US-20060211707-A1 Piperazine-alkyl-ureido derivatives ADRA2C, UTS2R, ADRB2 ALDH1A1 2026/4885CYP1A2 1001/4885MAPT 899/4885
US-20120219885-A1 NOVEL NON-CRYSTALLIZING METHACRYLATES, PRODUCTION AND USE THEREOF MEP1A, MMAB, RHOA ALDH1A1 3355/4885CYP1A2 1551/4885MAPT 299/4885
US-20060173027-A1 Spirocvclic piperidines as mch1 antagonists and uses thereof MCHR1, MCHR2, CRHR1 ALDH1A1 172/4885CYP1A2 1407/4885MAPT 2933/4885
US-20030064962-A1 Inhibitors of hepatitis C virus NS3 protease PRSS1, SERPINB1, SPINT2 ALDH1A1 362/4885CYP1A2 189/4885MAPT 3729/4885
US-20160346170-A1 ADDITION-FRAGMENTATION OLIGOMERS HAVING HIGH REFRACTIVE INDEX GROUPS ZYX, MACF1, PYCARD ALDH1A1 1234/4885CYP1A2 2852/4885MAPT 2195/4885
US-20050107456-A1 Substituted pyrazolines for use as pesticides DDT, ACHE, CHRM1 ALDH1A1 952/4885CYP1A2 12/4885MAPT 4247/4885
US-20040209928-A1 Glucagon receptor antagonists/inverse agonists GLP1R, GPR119, GCGR ALDH1A1 2866/4885CYP1A2 1531/4885MAPT 4677/4885
US-20070099955-A1 3-PIPERIDINYLISOCHROMAN-5-OLS AS DOPAMINE AGONISTS DRD3, DRD2, DRD4 ALDH1A1 241/4885CYP1A2 573/4885MAPT 1413/4885
US-10195119-B2 High refractive index addition-fragmentation agents EEF1G, FANCI, EEF1E1 ALDH1A1 1430/4885CYP1A2 3419/4885MAPT 4025/4885
US-20160279033-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS EEF1G, FANCI, EEF1E1 ALDH1A1 1430/4885CYP1A2 3419/4885MAPT 4025/4885
US-20080269271-A1 Analgesics; antidepressants; neurodegenerative diseases; antiepileptic agents; cognition activators; antitussive agents; incotinence; irritable bowel syndrome; stroke; vision defects; antiinflammatory agents; skin disorders; diarrhea; eating disorders INA, SCN1A, SI ALDH1A1 511/4885CYP1A2 2142/4885MAPT 161/4885
US-20050107388-A1 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain ARRB1, OPRL1, CNR1 ALDH1A1 1267/4885CYP1A2 464/4885MAPT 4195/4885
US-12145913-B2 Inhibition of Olig2 activity POU2F2, POU2F1, PLP2 ALDH1A1 1823/4885CYP1A2 3694/4885MAPT 743/4885
US-20070155835-A1 USE OF ORTHO-PHENYLPHENOL AND/OR DERIVATIVES THEREOF FOR INHIBITING THE ASEXUAL REPRODUCTION OF FUNGI TYR, HPD, ERG28 ALDH1A1 1350/4885CYP1A2 363/4885MAPT 2521/4885
US-20050038100-A1 Substituted urea neuropeptide Y Y5 receptor antagonists NPY5R, NPY1R, NPY2R ALDH1A1 4866/4885CYP1A2 4808/4885MAPT 1445/4885
US-20030008893-A1 Modulators of chemokine receptor activity CCR1, CCR3, CCR2 ALDH1A1 1764/4885CYP1A2 2570/4885MAPT 4154/4885
US-20050192265-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds BACE1, APP, BACE2 ALDH1A1 3776/4885CYP1A2 3219/4885MAPT 35/4885
US-20110294793-A1 HYDROXYPHENYL SULFONAMIDES AS ANTIAPOPTOTIC BCL INHIBITORS BCL2, BAX, BCL2A1 ALDH1A1 2465/4885CYP1A2 3399/4885MAPT 212/4885
US-20040106598-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting Beta-amyloid peptide release and/or its synthesis by use of such compounds BACE1, APP, BACE2 ALDH1A1 3970/4885CYP1A2 3381/4885MAPT 39/4885
US-20050042674-A9 Common ligand mimics: thiazolidinediones and rhodanines GPR65, NR2E3, FGFR3 ALDH1A1 1216/4885CYP1A2 1442/4885MAPT 3199/4885
US-20090182033-A1 Cyclic Amine Derivatives and Their Uses CHRM2, CHRM3, CHRM1 ALDH1A1 2672/4885CYP1A2 1106/4885MAPT 4542/4885
US-20060116398-A1 Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity ADRB2, ADRA2B, ADRB1 ALDH1A1 1173/4885CYP1A2 381/4885MAPT 3052/4885
US-11242323-B2 Inhibition of OLIG2 activity POU2F2, ING2, PAX2 ALDH1A1 1801/4885CYP1A2 4248/4885MAPT 1078/4885
US-10329244-B2 Moisture-stable holographic media NEFM, MDM4, BHMT2 ALDH1A1 3155/4885CYP1A2 2081/4885MAPT 343/4885
US-20070093414-A1 Hepatitis C virus inhibitors HAVCR2, HCCS, PYGL ALDH1A1 623/4885CYP1A2 436/4885MAPT 4108/4885
US-20110028442-A1 DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR ADRB2, ADRB1, ADRA2C ALDH1A1 469/4885CYP1A2 194/4885MAPT 2590/4885
US-20090306134-A1 Muscarinic receptor antagonists CHRM3, CHRM5, CHRM2 ALDH1A1 2335/4885CYP1A2 2058/4885MAPT 3022/4885
US-20050192269-A1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds BACE1, APP, BACE2 ALDH1A1 3776/4885CYP1A2 3219/4885MAPT 35/4885
US-20080182847-A1 4-AMINO-1H-PYRIMIDIN-2-ONE BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF THEIR USE TPMT, DHFR, GLS2 ALDH1A1 200/4885CYP1A2 301/4885MAPT 2186/4885
US-20050234090-A1 Modulators of chemokine receptor activity CCR3, CCR2, CCR1 ALDH1A1 1982/4885CYP1A2 2621/4885MAPT 4137/4885
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA NEFM, MDM4, BHMT2 ALDH1A1 3155/4885CYP1A2 2081/4885MAPT 343/4885
US-20190105237-A1 HIGH REFRACTIVE INDEX ADDITION-FRAGMENTATION AGENTS EEF1G, FANCI, EEF1E1 ALDH1A1 1430/4885CYP1A2 3419/4885MAPT 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.